Don’t Have a Nasopharyngeal Flocked Swab for COVID-19 Sample Collection? Are There Alternatives?

In this video, Norman Sharples, COPAN Diagnostics’ CEO, discusses the different sites and swab materials available for sample collection for COVID-19 based on the FDA Guidelines as of April 1, 2020.
FDA believes that a nasopharyngeal specimen is a preferred choice for swab-based SARS-CoV-2 testing. If a nasopharyngeal specimen is not available, then any of the following are acceptable:
Oropharyngeal specimen collected by a healthcare professional (HCP);
Mid-turbinate specimen by onsite self-collection or HCP (using a flocked tapered swab); or
Anterior nares specimen by onsite self-collection or HCP (using a round foam swab or polyester).
The situation regarding the types of sample collection kits acceptable for COVID-19 testing remains fluid. Consult the current guidance for information on sample collection systems at the
FDA Medical Devices Emergency Situations - FAQs on Diagnostic Testing for SARS-CoV-2: www.fda.gov/me...